Skip to main content
. 2021 Aug 13;8(5):4187–4198. doi: 10.1002/ehf2.13555

Figure 1.

Figure 1

Incidence of CV death (A), all‐cause death (B), MACE (C), and HF‐related hospitalization (D) according to the quartiles of baseline sVEGFR‐2 levels during the follow‐up period. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio, MACE, major adverse cardiovascular events defined as a composite of CV death and HF‐related hospitalization; Q, quartile; sVEGFR‐2, soluble vascular endothelial growth factor receptor 2.